Clinical Trials Logo

Clinical Trial Summary

Overactive bladder(OAB,Urgency) was determined by International Continence Society as Urinary urgency, usually accompanied by frequency and nocturia, with or without urgency urinary incontinence, in the absence of urinary tract infection (UTI) or other obvious pathology.The SNM treatment involves a two-stage surgical procedure performed under local anesthesia. The device include IPG (implantable programme generator) and lead. In the initial test phase, 1st stage, electrode is placed near the sacral nerve and requires a 2 weeks assessment. This allows your doctors and you to assess your initial response according to your voiding dairy and satisfaction. In 2nd stage, SNM procedure is implantation of the IPG.

X ray guidance is harmful to both patients and doctors, while ultrasound guidance is real time visual guidance ,easy to operate by doctors and a radiation free option to challenge anatomy. Urologists are skilled in both ultrasound operations and anatomy basics and dedicating to developing better guidance technique in surgery.

The study here compare the efficacy and safety of ultrasound versus X ray guidance technique in SNM.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02946723
Study type Interventional
Source Beijing Pins Medical Co., Ltd
Contact Fumin Jia, PhD
Phone 010-59361265
Email pins_medical@163.con
Status Not yet recruiting
Phase Phase 1
Start date February 2017
Completion date February 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02619721 - Clinical Trial of Sacral Neuromodulation for Treatment of Refractory Overactive Bladder (OAB) Phase 0
Completed NCT01525485 - Vaginal Electrical Stimulation Versus Neuromodulation N/A